Search research articles
Contact Us
Filters
Showing results (891-900 of 1,281) with videos related to
Page
of 129
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2005
Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer
Donald Bissett, Ken J O'Byrne, J von Pawel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance
Grainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Obesity (Silver Spring, Md.)
|
March 7, 2022
Subcutaneous and visceral fat assessment by DXA and MRI in older adults and children
Gertraud Maskarinec, Yurii B Shvetsov, Michael C Wong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective project
Dorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 23, 2009
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation
Jean-Yves Douillard, Hélène Tribodet, Delphine Aubert, et al.
Nature Chemical Biology
|
July 16, 2013
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry
Maike C Jürgens, Judit Vörös, Gilles J P Rautureau, et al.
Nucleic Acids Research
|
February 21, 2014
Domain movements of the enhancer-dependent sigma factor drive DNA delivery into the RNA polymerase active site: insights from single molecule studies
Amit Sharma, Robert N Leach, Christopher Gell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
P Mitchell, N Thatcher, M A Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial
R L Burkes, R J Ginsberg, F A Shepherd, et al.
European Journal of Clinical Nutrition
|
January 26, 2020
Differences in the association of diet quality with body fat distribution between men and women
Gertraud Maskarinec, Lisa A Namatame, Minji Kang, et al.
Page
of 129
Search research articles
Search
Showing results (891-900 of 1,281) with videos related to
Sort By:
Page
of 129
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 2005
Phase III study of matrix metalloproteinase inhibitor prinomastat in non-small-cell lung cancer
Donald Bissett, Ken J O'Byrne, J von Pawel, et al.
Lung Cancer (Amsterdam, Netherlands)
|
April 28, 2019
The presence and variant allele fraction of EGFR mutations in ctDNA and development of resistance
Grainne M O'Kane, Geoffrey Liu, Tracy L Stockley, et al.
Obesity (Silver Spring, Md.)
|
March 7, 2022
Subcutaneous and visceral fat assessment by DXA and MRI in older adults and children
Gertraud Maskarinec, Yurii B Shvetsov, Michael C Wong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
May 23, 2009
The IASLC Lung Cancer Staging Project: data elements for the prospective project
Dorothy J Giroux, Ramón Rami-Porta, Kari Chansky, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 23, 2009
Adjuvant cisplatin and vinorelbine for completely resected non-small cell lung cancer: subgroup analysis of the Lung Adjuvant Cisplatin Evaluation
Jean-Yves Douillard, Hélène Tribodet, Delphine Aubert, et al.
Nature Chemical Biology
|
July 16, 2013
The hepatitis B virus preS1 domain hijacks host trafficking proteins by motif mimicry
Maike C Jürgens, Judit Vörös, Gilles J P Rautureau, et al.
Nucleic Acids Research
|
February 21, 2014
Domain movements of the enhancer-dependent sigma factor drive DNA delivery into the RNA polymerase active site: insights from single molecule studies
Amit Sharma, Robert N Leach, Christopher Gell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 28, 2015
Tecemotide in unresectable stage III non-small-cell lung cancer in the phase III START study: updated overall survival and biomarker analyses
P Mitchell, N Thatcher, M A Socinski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1992
Induction chemotherapy with mitomycin, vindesine, and cisplatin for stage III unresectable non-small-cell lung cancer: results of the Toronto Phase II Trial
R L Burkes, R J Ginsberg, F A Shepherd, et al.
European Journal of Clinical Nutrition
|
January 26, 2020
Differences in the association of diet quality with body fat distribution between men and women
Gertraud Maskarinec, Lisa A Namatame, Minji Kang, et al.
Page
of 129